ES530681A0 - Procedimiento para preparar derivados de (indenil-2)-2-imidazolina - Google Patents
Procedimiento para preparar derivados de (indenil-2)-2-imidazolinaInfo
- Publication number
- ES530681A0 ES530681A0 ES530681A ES530681A ES530681A0 ES 530681 A0 ES530681 A0 ES 530681A0 ES 530681 A ES530681 A ES 530681A ES 530681 A ES530681 A ES 530681A ES 530681 A0 ES530681 A0 ES 530681A0
- Authority
- ES
- Spain
- Prior art keywords
- indenil
- imidazoline
- procedure
- preparing derivatives
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/06—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D233/22—Radicals substituted by oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8304524A FR2542738A1 (fr) | 1983-03-18 | 1983-03-18 | Indanyl-2 d2-imidazoline, procede pour la preparer, et compositions pharmaceutiques qui la contiennent |
Publications (2)
Publication Number | Publication Date |
---|---|
ES8500907A1 ES8500907A1 (es) | 1984-11-01 |
ES530681A0 true ES530681A0 (es) | 1984-11-01 |
Family
ID=9287026
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES530681A Granted ES530681A0 (es) | 1983-03-18 | 1984-03-16 | Procedimiento para preparar derivados de (indenil-2)-2-imidazolina |
Country Status (16)
Country | Link |
---|---|
US (1) | US4559356A (es) |
EP (1) | EP0125937A2 (es) |
JP (1) | JPS59186962A (es) |
AU (1) | AU559177B2 (es) |
CA (1) | CA1217776A (es) |
DK (1) | DK112884A (es) |
ES (1) | ES530681A0 (es) |
FI (1) | FI841077A (es) |
FR (1) | FR2542738A1 (es) |
GR (1) | GR81885B (es) |
HU (1) | HU191597B (es) |
IL (1) | IL71270A0 (es) |
NO (1) | NO841021L (es) |
NZ (1) | NZ207524A (es) |
PT (1) | PT78272B (es) |
ZA (1) | ZA841985B (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3583900D1 (de) * | 1984-06-06 | 1991-10-02 | Abbott Lab | Adrenergische verbindungen. |
GB2167408B (en) * | 1984-11-23 | 1988-05-25 | Farmos Oy | Substituted imidazole derivatives and their preparation and use |
FR2787451B1 (fr) * | 1998-12-18 | 2001-01-26 | Adir | Nouveaux composes imidazoliniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
AU778522B2 (en) * | 1999-10-29 | 2004-12-09 | Orion Corporation | Treatment or prevention of hypotension and shock |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2731471A (en) * | 1956-01-17 | Nxg hi | ||
US2842478A (en) * | 1955-08-25 | 1958-07-08 | Pfizer & Co C | Tetrahydrozoline-central nervous system depressant veterinary compositions and method of using same |
US3287469A (en) * | 1963-09-27 | 1966-11-22 | Du Pont | Naphthyl-and indanylimidazolines |
-
1983
- 1983-03-18 FR FR8304524A patent/FR2542738A1/fr active Pending
-
1984
- 1984-02-28 DK DK112884A patent/DK112884A/da not_active Application Discontinuation
- 1984-03-09 EP EP84400485A patent/EP0125937A2/fr not_active Withdrawn
- 1984-03-16 GR GR74127A patent/GR81885B/el unknown
- 1984-03-16 NO NO841021A patent/NO841021L/no unknown
- 1984-03-16 IL IL71270A patent/IL71270A0/xx unknown
- 1984-03-16 PT PT78272A patent/PT78272B/pt unknown
- 1984-03-16 AU AU25819/84A patent/AU559177B2/en not_active Expired - Fee Related
- 1984-03-16 FI FI841077A patent/FI841077A/fi not_active Application Discontinuation
- 1984-03-16 ZA ZA841985A patent/ZA841985B/xx unknown
- 1984-03-16 US US06/590,355 patent/US4559356A/en not_active Expired - Fee Related
- 1984-03-16 CA CA000449793A patent/CA1217776A/en not_active Expired
- 1984-03-16 HU HU841051A patent/HU191597B/hu unknown
- 1984-03-16 NZ NZ207524A patent/NZ207524A/en unknown
- 1984-03-16 JP JP59052071A patent/JPS59186962A/ja active Pending
- 1984-03-16 ES ES530681A patent/ES530681A0/es active Granted
Also Published As
Publication number | Publication date |
---|---|
FI841077A (fi) | 1984-09-19 |
GR81885B (es) | 1984-12-12 |
NO841021L (no) | 1984-09-19 |
HU191597B (en) | 1987-03-30 |
AU559177B2 (en) | 1987-02-26 |
PT78272A (fr) | 1984-04-01 |
CA1217776A (en) | 1987-02-10 |
DK112884A (da) | 1984-09-19 |
US4559356A (en) | 1985-12-17 |
ES8500907A1 (es) | 1984-11-01 |
FI841077A0 (fi) | 1984-03-16 |
FR2542738A1 (fr) | 1984-09-21 |
DK112884D0 (da) | 1984-02-28 |
AU2581984A (en) | 1984-09-20 |
PT78272B (fr) | 1986-08-08 |
ZA841985B (en) | 1984-10-31 |
EP0125937A2 (fr) | 1984-11-21 |
HUT34165A (en) | 1985-02-28 |
IL71270A0 (en) | 1984-06-29 |
JPS59186962A (ja) | 1984-10-23 |
NZ207524A (en) | 1986-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES532765A0 (es) | Procedimiento para preparar derivados de 3-bencilidenalcanfor | |
ES526381A0 (es) | Procedimiento para preparar derivados de fenil-1-piperidino-2-propanol | |
ES535978A0 (es) | Procedimiento para preparar derivados de tiazol | |
ES539563A0 (es) | Un procedimiento para preparar derivados de fenilamino-mer- captoimidazol | |
ES536138A0 (es) | Procedimiento para preparar derivados azolicos | |
ES544286A0 (es) | Procedimiento para la preparacion de nuevos derivados tiazo-lidinicos | |
ES557808A0 (es) | Un procedimiento para preparar derivados de octahidro(f) quinoleina | |
ES539255A0 (es) | Procedimiento para preparar derivados de isoquinoleina | |
MX159669A (es) | Procedimiento para la preparacion de derivados de acilamida | |
ES536786A0 (es) | Procedimiento para preparar derivados de imidazolina | |
ES533497A0 (es) | Procedimiento para la preparacion de nuevos derivados de 3-fenil-4-cianopirrol | |
ES534377A0 (es) | Procedimiento para preparar derivados de antraciclina | |
MX7403E (es) | Procedimiento para preparar derivados de benzoil-ureas | |
ES530574A0 (es) | Procedimiento para preparar derivados de pirazol 1,5-a-piridina | |
ES554371A0 (es) | Procedimiento para preparar derivados de benzisoselenazolilo | |
ES530681A0 (es) | Procedimiento para preparar derivados de (indenil-2)-2-imidazolina | |
ES530573A0 (es) | Procedimiento para preparar derivados de pirazol-1,5-a-piridina | |
ES530626A0 (es) | Procedimiento para preparar derivados de ciano-2-imidazopiridina | |
ES530989A0 (es) | Procedimiento para preparar derivados de pirazolpiridina | |
ES537098A0 (es) | Un procedimiento para preparar derivados de tiadiazina | |
ES499421A0 (es) | Procedimiento para preparar derivados de indano | |
ES532212A0 (es) | Procedimiento para la obtencion de compuestos de 2-heterociclil-alquilo inferior-2-penem | |
ES538957A0 (es) | Procedimiento para preparar derivados de pirazolpiridina | |
ES532142A0 (es) | Procedimiento para preparar derivados acilaminofenolicos | |
ES536664A0 (es) | Procedimiento para la obtencion de derivados de azolil-tetrahidro-furan-2-iliden-metano |